(Q26799782)

23 March 2019

21 March 2019

20 June 2019

19 October 2019

1 July 2020

on focus list of Wikimedia project

25 October 2022

ScienceSource

0 references

cites work

Hepatitis B virus infection in HIV-positive individuals in the UK collaborative HIV cohort (UK CHIC) study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: a review.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Epidemiology and impact of HIV coinfection with hepatitis B and hepatitis C viruses in Sub-Saharan Africa.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Vaccination coverage against hepatitis A and B viruses, Streptococcus pneumoniae, seasonal flu, and A(H1N1)2009 pandemic influenza in HIV-infected patients.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Effectiveness of 10-year vaccination (2001-2010) on Hepatitis A in Tianjin, China

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Comparison of immunogenicity and safety of four doses and four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: a randomized, controlled trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Impact of a new vaccine clinic on hepatitis B vaccine completion and immunological response rates in an HIV-positive cohort

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Duration of protection against hepatitis A for the current two-dose vaccine compared to a three-dose vaccine schedule in children

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Does increased hepatitis B vaccination dose lead to a better immune response in HIV-infected patients than standard dose vaccination: a meta-analysis?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Which patients respond best to hepatitis B vaccination after a hepatitis B virus-related liver transplantation?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Hepatitis A vaccine response in HIV-infected patients: are TWINRIX and HAVRIX interchangeable?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Long-term immunogenicity of hepatitis A virus vaccine in Alaska 17 years after initial childhood series

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Immune response to hepatitis B virus vaccination among HIV-1 infected and uninfected adults in Kenya

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Vaccination against viral hepatitis of HIV-1 infected patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Hepatitis A: Epidemiology and prevention in developing countries

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Persistence of Protective Hepatitis B Surface Antibody Titers after Successful Double-Dose Hepatitis B Virus Rescue Vaccination in HIV-Infected Patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

GM-CSF Fails to Improve Immune Responses to Booster Hepatitis B Vaccination in HIV-Infected Individuals

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Long-term durability of immune responses after hepatitis A vaccination among HIV-infected adults.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Factors associated with seroconversion after standard dose hepatitis B vaccination and high-dose revaccination among HIV-infected patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Hepatitis A virus seroprevalence by age and world region, 1990 and 2005.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Efficacy of double-dose hepatitis B rescue vaccination in HIV-infected patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Long-term protection provided by hepatitis B vaccine and need for booster dose: a meta-analysis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Hepatitis B vaccination in HIV-infected adults: current evidence, recommendations and practical considerations

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Hepatitis B and human immunodeficiency virus coinfection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Independent clinical predictors of impaired response to hepatitis B vaccination in HIV-infected persons

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Seroprevalence of viral hepatitis and sexually transmitted disease among adults with recently diagnosed HIV infection in Southern Taiwan, 2000-2005: upsurge in hepatitis C virus infections among injection drug users

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Vaccination in Brazilian HIV-infected adults: a cross-sectional study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Factors for predicting successful immune response to hepatitis B vaccination in HIV-1 infected patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Hepatitis A in the era of vaccination

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Activated CD4+CD25+ T cells selectively kill B lymphocytes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Epidemiology of viral hepatitis and HIV co-infection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

The effectiveness and safety of hepatitis A vaccine: a systematic review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Risk groups for hepatitis A virus infection.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Comparative safety of two recombinant hepatitis B vaccines in children: data from the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink (VSD).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

The utilisation of hepatitis A vaccine 1992-1994.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Clinical aspects of the interactions between human immunodeficiency virus and the hepatotropic viruses

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Vaccination coverage and immunity against hepatitis B among HIV-infected patients in South Brazil

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

HIV/AIDS coinfection with the hepatitis B and C viruses in Brazil.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Durability of response to vaccination against viral hepatitis A in HIV-infected patients: a 5-year observation

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Hepatitis A vaccination and immunological parameters in HIV-infected patients

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Long-term response rates of successful hepatitis B vaccination in HIV-infected patients

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Randomized controlled trial of Hepatitis B virus vaccine in HIV-1-infected patients comparing two different doses

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Prevalence of hepatitis viruses in an anti-human immunodeficiency virus-positive population from Argentina. A multicentre study

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

The effect of immunization with inactivated hepatitis A vaccine on the clinical course of HIV-1 infection: 1-year follow-up

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Safety and immunogenicity of a purified hepatitis B virus vaccine prepared by using recombinant DNA technology

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Clinical reactivation of hepatitis B in anti-HBs-positive patients with AIDS.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B virus carrier state

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Influence of human immunodeficiency virus type 1 infection on acute hepatitis A virus infection

31 May 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1055424

HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1055424

Prevalence of chronic hepatitis B virus infection among patients in the HIV Outpatient Study, 1996-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1055424

The effect of concurrent human immunodeficiency virus infection on chronic hepatitis B: a study of 150 homosexual men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1055424

Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1055424

Efficacy of hepatitis B vaccination and revaccination and factors impacting on response in patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1055424

A prospective open study of the efficacy of high-dose recombinant hepatitis B rechallenge vaccination in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1055424

Efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant for hepatitis B virus in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1055424

Humoral response to hepatitis B vaccination and its relationship with T CD45RA+ (naïve) and CD45RO+ (memory) subsets in HIV-1-infected subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1055424

The recombinant hepatitis B surface antigen vaccine in persons with HIV: is seroconversion sufficient for long-term protection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1055424

Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1055424

Epidemiology of hepatitis A in Finland in 1990-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1055424

Quantifying the impact of hepatitis A immunization in the United States, 1995-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1055424

Immunogenicity and safety in adults of hepatitis A virus vaccine administered as a single dose with a booster 6 months later

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1055424

Incidence of hepatitis A in Israel following universal immunization of toddlers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1055424

Long-term clinical observation of the immunogenicity of inactivated hepatitis A vaccine in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1055424

Predicted 30-year protection after vaccination with an aluminum-free virosomal hepatitis A vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1055424

A post-licensure evaluation of the safety of inactivated hepatitis A vaccine (VAQTA, Merck) in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1055424

An open, prospective, randomized study comparing the immunogenicity and safety of two inactivated hepatitis A pediatric vaccines in toddlers, children and adolescents in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1055424

Safety and immunogenicity of an inactivated hepatitis A vaccine among HIV-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1055424

Response to hepatitis A vaccine in HIV-positive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1055424

Immunological efficacy of a three-dose schedule of hepatitis A vaccine in HIV-infected adults: HEPAVAC study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1055424

Comparative effectiveness of two doses versus three doses of hepatitis A vaccine in human immunodeficiency virus-infected and -uninfected men who have sex with men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1055424

Safety and Immunogenicity of Hepatitis A Vaccine in Human Immunodeficiency Virus–Infected Patients: A Double‐Blind, Randomized, Placebo‐Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1055424

Long-term persistence of humoral immunity after hepatitis A vaccination in HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1055424

Immunogenicity and safety of a pediatric dose virosomal hepatitis A vaccine in Thai HIV-infected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1055424

Recommendations for identification and public health management of persons with chronic hepatitis B virus infection

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685678

Response to hepatitis A vaccine in HIV patients in the HAART era

28 November 2018

1 reference

https://api.crossref.org/works/10.1080%2F21645515.2015.1055424

Immune response to hepatitis A vaccination in HIV-infected men in Greece

21 January 2018

1 reference

12 December 2020

The nonresponse to hepatitis B vaccination is associated with impaired lymphocyte activation

1 reference

12 December 2020

Undetectable plasma HIV RNA load predicts success after hepatitis B vaccination in HIV-infected persons

1 reference

12 December 2020

Assessing the immunological response to hepatitis B vaccination in HIV-infected patients in clinical practice

1 reference

12 December 2020

Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

12 December 2020

Hepatitis B antibodies in HIV-infected homosexual men are associated with more rapid progression to AIDS

1 reference

12 December 2020

Role of CD4 count in immunity development after hepatitis A and B vaccination among HIV-infected patients: Kentucky, 2002-2007

1 reference

12 December 2020

Prolonged hepatitis A infection in an HIV-1 seropositive patient

1 reference

12 December 2020

What level of hepatitis B antibody is protective?

1 reference

12 December 2020

Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose

1 reference

12 December 2020

Predictors of immunity after hepatitis A vaccination in HIV-infected persons

1 reference

12 December 2020

Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes

1 reference

12 December 2020

Fulminant Hepatitis Associated with Hepatitis A Virus Superinfection in Patients with Chronic Hepatitis C

1 reference

12 December 2020

Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age

1 reference

12 December 2020

High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected adults subjects

1 reference

12 December 2020

Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients

1 reference

12 December 2020

Protection against hepatitis A by an inactivated vaccine

1 reference

12 December 2020

Hepatitis A incidence and hepatitis a vaccination among American Indians and Alaska Natives, 1990-2001

1 reference

12 December 2020

British HIV Association guidelines for immunization of HIV-infected adults 2008

1 reference

12 December 2020

Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies

1 reference

12 December 2020

Influence of smoking on immunological responses to hepatitis B vaccine

1 reference

12 December 2020

WHO position paper on hepatitis A vaccines – June 2012

1 reference

12 December 2020

Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults

1 reference

12 December 2020

10.1080/21645515.2015.1055424

Identifiers

DOI

1 reference

1 reference

1 reference

PubMed publication ID

26208678

1 reference